Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Triple Threat – Glaxon’s New and Improved Plasm Surge Blend Features Three of Kyowa Hakko’s Branded Ingredients


News Image

Sports nutrition dietary supplement brand Glaxon launches Plasm Surge, a non-stimulant pre-workout product with a new and improved formula and flavor system, featuring leading international health-ingredient manufacturer Kyowa Hakko’s Setria® Performance Blend, Velox® Patented Performance Blend and Kyowa Quality L-Citrulline.

“Glaxon is in pursuit of fostering an engaging community that leverages biology and performance via sports nutrition in pursuit of human betterment,” comments Michael Bischoff, founder of Glaxon, “Our goal is to empower consumers to be better physically, mentally and spiritually, that’s why we made it a priority to formulate our Plasm Surge product with cutting-edge ingredients that are backed by science. For that reason, we selected three of Kyowa Hakko’s novel performance blends and ingredients, helping to harness the nitric oxide pathway from different points.”

A key feature of the pre-workout blend is Kyowa Quality L-Citrulline, a research-backed, non-essential amino acid that plays an important role in nitric oxide (NO) metabolism and regulation*. L-Citrulline is converted to L-Arginine in the body to support L-Arginine and nitric oxide levels*. Increased production of NO promotes vascular dilation which improves oxygen and blood circulation throughout the body*. L- Citrulline is also expected to relieve muscle fatigue through ammonia elimination*.

The Kyowa Quality L-Citrulline ingredient is part of Kyowa Hakko’s extensive line of quality-assured ingredients. These ingredients exceed commodity ingredients in purity, quality and safety, made in the USA and are distinguished from mainstream commodity ingredients by the Kyowa Quality logo.

In addition to Kyowa Quality L-Citrulline, Plasm Surge also contains Kyowa Hakko’s VELOX® Patented Performance Blend and its Setria® Performance Blend. VELOX® is a clinically studied combination of Kyowa’s L-Citrulline and Kyowa’s L-Arginine that has been shown to increase nitric oxide production and to boost nitric oxide levels more rapidly than L-Arginine alone*. VELOX® is clinically studied to rapidly increase blood Arginine levels*, increase power output*, reduce muscle soreness*, and synergistically increase blood Arginine levels*. It is a patented nitric oxide booster* that is manufactured through Kyowa Hakko’s fermentation process, ensuring purity and no added chemicals.

Kyowa Hakko’s Setria® Performance Blend is a unique combination of Setria® Glutathione and L-Citrulline, and is backed by research suggesting it may help and support NO levels post-workout*, sustain NO levels post-workout* and aid in vasodilation to help fuel muscles*.

“It is so exciting to have our Kyowa Quality L-Citrulline ingredient, along with two of our leading performance blends, all included within this innovative pre-workout product. As a company that strives for advancement and innovation within the dietary supplement industry, we are taking this as a huge win,” comments Elyse Lovett, MS, MBA, Senior Marketing Manager of Kyowa Hakko U.S.A. Inc.

Glaxon’s Plasm Surge is available for purchase online at http://www.glaxon.com and comes in Juicy Apple, Americanade or unflavored options.

Media interested in setting up an interview with a Kyowa Hakko representative, please contact Sara White: sara@adinnyc.com or 914.621.1323.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

###

About Kyowa Quality L-Citrulline:

L-Citrulline is an amino acid that plays an important role in nitric oxide metabolism and regulation. L-Citrulline is converted to L-Arginine in the body, leading to sustained increases in both L-Arginine and nitric oxide. An ingredient with application in the areas of heart health and sports nutrition, L-Citrulline is preservative-free, allergen-free, and contains no artificial flavors or colors. It’s non-hygroscopic, highly stable, and mild taste make it suitable for use in a variety of formulations. This pure, vegetarian ingredient is also NON-GMO and self-affirmed GRAS. Manufactured in the U.S. using an innovative fermentation process, L-Citrulline is a pure amino acid that carries the KyowaQuality® logo, ensuring the ingredient is backed by our commitment to the highest manufacturing standards.

About VELOX® Patented Performance Blend:

VELOX® Patented Performance Blend is a combination of Kyowa’s L-Citrulline and Kyowa’s L-Arginine. The effective dosage requires a minimum of 1.2 grams of Kyowa’s L-Citrulline and 1.2 grams of Kyowa’s L-Arginine, and a ratio of 1:1 of Kyowa L-Citrulline and Kyowa L-Arginine to support claims. VELOX® Patented Performance Blend is clinically studied to rapidly increase blood Arginine levels*, increase power output*, reduce muscle soreness*, and synergistically increase blood Arginine levels*. VELOX ® is protected by four US Patents: U.S. Patent 8,609,735, U.S. Patent 9,060,980, U.S. Patent 9,622,998, and U.S. Patent 10,052,298

About Setria® Performance Blend:

Setria® Performance Blend is a, branded, patented blend of L-citrulline and Setria® glutathione – Kyowa’s Setria® Performance Blend. Studies have shown that this blend supports nitric oxide production and sustains nitric oxide levels in the bloodstream.

About Kyowa Hakko USA:

Kyowa Hakko USA is the North & South American office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals and food products. For more information visit Kyowa-USA.com.

Share article on social media or email:

New UVc Tabletop Device Effectively Disinfects N95 Masks and PPE


Hepius N9500 Tabletop UVc Disinfector

“Our professional staff was relieved to find a decontamination device that effectively disinfects their masks and PPE. And when we considered the financial impact of having a member of our staff out with a 14-day quarantine, the N9500 was the perfect solution. ” — Dillard Dental Services

Hepius Equipment announces the availability of the N9500 Decontamination Device. Designed in conjunction with the medical staff of Parkland Hospital in Dallas, Texas, the N9500 is an FDA Listed Class I medical device designed to save time and money by allowing the reuse of N95 masks and Personal Protection Equipment (PPE). This easy-to-use sanitizer – previously available only to hospital facilities – is now being rapidly made available for schools, hotels, dental offices, long-term care facilities and other consumer facing industries.

The Hepius N9500 has been demonstrated to disable viruses with a 99.9% antimicrobial efficacy* making it especially effective in decontaminating N95 respirator masks as well as other PPE including full face shields. Repeated use of the N9500 to decontaminate masks does not affect filtration effectiveness or fit. The N9500 is available for sale in the US and for US Export.

The convenient Hepius N9500 Tabletop disinfector uses Ultraviolet Germicidal Irradiation (specifically UVc light) to inactivate and destroy pathogens. UVc disinfection damages the DNA and genetic makeup of the organism causing inability to replicate and/or cell death.

Built and certified in the USA to exacting standards, the Hepius N9500 is designed for PPE and is engineered to decontaminate 240,000 masks before first required maintenance.

The Hepius N9500 Advantage:


  • Removes growing uncertainty of N95 mask and PPE supply issues
  • Minimizes financial loss from potential 14-day quarantine of staff and personnel
  • Avoids polycarbonate breakdown associated with harsh cleaning solutions
  • Is more cost effective than throw-away masks
  • Environmentally friendly while reducing medical waste

*Microchem Laboratory testing funded by Hepius Equipment.

Share article on social media or email:

Facet Life Sciences Releases On-Line Collaboration for Gemstone


Gemstone

Collaborate with Gemstone

“We developed Gemstone to provide big company capabilities at a small company price. This latest release with the new collaboration features is a game changer for companies who want to work simultaneously or dynamically on regulatory content creation in a controlled environment.”

Facet Life Sciences, a leading provider of development software and services for small and growing life sciences teams, today announced the release of on-line collaborative authoring as part of its latest Gemstone Electronic Document Management System (EDMS) release.

Gemstone is an affordable, cloud-based document management system designed for small research and development teams & start-ups. The new release includes enhancements that enable users to create, share, preview, collaborate, edit, store, and archive documents in a system that is fully compliant with US and EU document management requirements.

Gemstone has always provided the ability to add, modify, or preview documents. With this new release, Gemstone adds the ability to initiate an on-line collaboration session to dynamically modify or comment on a document currently stored in Gemstone, individually or with colleagues. Whether you are in the same room or across the world, share and collaborate on documents in real time.

Features:

  • Collaboration helps speed your documents to finalization. Your team can make comments and track edits dynamically in Word documents in Office 365, all fully managed by the Gemstone system.
  • Email notifications are sent to team members invited to collaborate and a convenient link is provided directly to the collaboration document in the system.
  • Collaboration is fully integrated into Gemstone, a secure, compliant document management system.

Ken VanLuvanee, President and CEO, Facet Life Sciences, commented, “We developed Gemstone to provide big company capabilities at a small company price. This latest release with the new collaboration features is a game changer for companies who want to work simultaneously or dynamically on regulatory content creation in a controlled environment.”

Gemstone still comes with flexible licensing options and user roles, including EDMS, Submissions and read-only seats.

About Facet Life Sciences

Facet Life Sciences is the leading provider of innovative development solutions (software and services) designed to help small teams get to and through the FDA©. Our Product Development Champions deliver expert nonclinical, CMC, and clinical regulatory services using cutting-edge technologies that speed product R&D efforts. Facet teams create and manage critical development documentation for some of the industry’s fastest growing, most innovative life sciences companies. https://facetlifesciences.com

Share article on social media or email:

New inpatient hospice units allow patients improved access to a continuum of services during COVID-19


Access to an organized inpatient hospice unit or facility can dramatically reduce the numbers of deaths in hospitals.

The novel coronavirus (COVID-19) has created turmoil in the hospital and post-acute environment. HealthPivots’ recent whitepaper describes an increase in demand for hospice services from patients hospitalized with COVID-19 diagnoses. HealthPivots’ hospice clients are on the front line of helping the terminal subset of these COVID-19 patients and their families that opt for hospice care. Several of these hospices have determined that there is a need, driven in part by COVID-19, for general inpatient hospice care in their local communities and hospitals.

Using HealthPivots’ Hospital-Based Unit Model, a well-utilized planning tool available in HealthPivots DataLab, these organizations are making intelligent development decision.

Heart of Hospice’s temporary inpatient unit, created as a ‘pop-up’ unit to serve COVID-19 patients in Louisiana, will now be a permanent service available to all patients. According to Carla Davis, CEO of Heart of Hospice, “When we were determining whether there was a need for a permanent hospice inpatient unit in New Orleans, the HealthPivots Hospital-Based Planning Model helped us determine not only that a need existed, but also the best location and size for our unit. The tool’s rich and detailed data analytics gave us confidence that we were making the best choice for our company and our community.”

Over the last few months, HealthPivots has observed a 30% increase in the use of this analytic planning model, developed to support hospices and hospitals in determining the right number of hospice inpatient beds to place in a hospital. The Hospital-Based Unit Model, vetted by a number of clients, formulates this analysis by combining data drawn from recent Medicare Fee-For-Service claims with a selection of modifiable assumptions. Chapters Health System, a HealthPivots DataLab client, provides hospice services to over 20 counties in Florida. Chief Financial Officer, David O’Neil, states “Inpatient hospice care is a core element of Chapters Health hospice program, and we have relied on HealthPivots DataLab for determining the need for hospice facilities for over eight years. HealthPivots’ analytic tools provide a flexible and reliable means of assessing the need for and potential utilization of hospice beds. Chapters Health is currently using HealthPivots DataLab to plan for additional development in the communities we serve.”

Covenant Care provides hospice services to 27 counties in Florida and Alabama. Odin Berg, Vice President – Strategy, states “Covenant Care has utilized the HealthPivots Hospital-Based Unit Model to determine bed capacity demand at various hospitals, and currently operates inpatient units at two of these hospitals. The tool accurately predicted bed demand at both hospitals. We were pleased with the results and plan to continue to use the tool for future inpatient unit planning and projects.”    

Jay Cushman, President and CEO of HealthPivots, summarizes the benefits and bottom line as follows. “Our approach is based on our observation that good access to an organized inpatient hospice unit or facility can dramatically reduce the numbers of deaths in hospitals.”

Hospices and hospitals interested in utilizing the Hospital-Based Unit Model resource can request a free analysis from HealthPivots.

About HealthPivots

HealthPivots supports integrated healthcare systems, hospices, home health agencies, skilled nursing facilities and hospitals as they strive to improve their marketplace performance, enhance partnerships with other agencies and improve outcomes for patients. HealthPivots provides HealthPivots DataLab, a premier web-based analytics solution, as well as custom printed business intelligence reports.

Share article on social media or email:

Verge Genomics Announces Publication of New Approach for Uncovering Novel Drug Targets from Human Genetics


“Designing medicines that functionally counteract known genetic causes of disease is core to our strategy to unlock clinical success in neurodegeneration.” Alice Zhang, CEO of Verge Genomics

Verge Genomics, a drug discovery company developing therapies for neurological diseases by integrating a unique all-in-human genomic platform with machine learning, announced today the publication of an original scientific research paper in the journal PLOS Computational Biology, a journal of the Public Library of Science in association with the International Society for Computational Biology.

Over the last decade analysis of human genetic data has revealed hundreds of genetic variants associated with disease. Yet, a major bottleneck to using this data for drug development is understanding how changes in DNA sequence ultimately result in disease, often requiring long and expensive experimentation. This paper describes a novel computational method developed at the company named BAGEA that uncovers the functional impact of genetic mutations using only the genome sequence. The paper illustrates BAGEA’s ability to predict the effects of genetic variants and validates its predictive power in a number of tissues and cell types.

“Designing medicines that functionally counteract known genetic causes of disease is core to our strategy to unlock clinical success in neurodegeneration. Key to this strategy is understanding the functional impact of disease causing genetic mutations, which may lead to therapies that are effective in more patients than those focused solely on correcting the mutation,” said Alice Zhang, CEO and Co-Founder of Verge Genomics, “We are excited by this novel statistical approach that allows us to more effectively mine large human genetic datasets to identify previously undiscovered drivers of disease. The peer-review and publication of this paper is an important independent examination of our platform and approach.”

Verge develops medicines that functionally counteract known genetic mutations in defined patient populations, but with broad translational potential. Its platform is designed to identify convergent pathways shared by multiple genetic drivers of disease by integrating multiple types of human data. The paper published in PLOS Computational Biology by Lamparter et al. describes the development of a method to map the consequences of genetic variation, including gene expression, enabling a better understanding of the pathways through which genetic mutations may act to cause disease. Furthermore, the method predicts the directional impact of each genetic variant, which enables scientists to develop more precise therapeutic hypotheses about whether inhibition or activation is appropriate for treating disease.

“Our new approach allows us to combine gene expression data with epigenomic data giving us a new understanding of gene regulators, their importance in given cell types, and whether they act as gene activators or gene inhibitors” said Victor Hanson-Smith, Head of Computational Biology at Verge,. “This information will allow us to uncover new biological targets that can be used to develop drugs that either enhance or inhibit genes involved in disease processes. This is the first of several methods we have been developing to further our mission of bringing new treatments to patients with neurological diseases like ALS and Parkinson’s Disease.”

The paper published in PLOS Computational Biology is titled, “A framework for integrating directed and undirected annotations to build explanatory models of cis-eQTL data”, and can be accessed here.

About Verge Genomics

Verge is focused on developing therapeutics for neurological diseases using human genomics to accelerate drug discovery. Verge has created a proprietary all-in-human platform, generating one of the field’s largest and most comprehensive databases of ALS and Parkinson’s Disease patient genomic data. The Company is led by experienced computational biologists and drug developers who are successfully advancing therapeutic programs in ALS and Parkinson’s disease toward the clinic. For additional information, please visit http://www.vergegenomics.com.

Contacts

for Verge Genomics

general@vergegenomics.com

Share article on social media or email:

Olympic Hot Tub’s 4th Annual Founder’s Event, October 2020


Olympic Hot Tub kicks off its 4th Annual Founder’s Event by shining a light to help end hunger by supporting three regional food banks serving communities in the Puget Sound area. The event honors founders Alice Cunningham and Blair Osborn and their legacy of giving. This year Olympic Hot Tub selected these deserving beneficiaries: the Marysville Community Food Bank, the Rainier Valley Food Bank in Seattle, and Eloise’s Cooking Pot Food Bank in Tacoma. These institutions have been pushed to their limits by overwhelming community need during the pandemic. Past Founder’s Event recipients include Path with Art, and the GSBA Scholarship Fund.

“Alice & Blair, both brilliant businesspeople, were passionate about a number of worthwhile causes. They shared a concern about the ever-growing plight of hunger and homelessness in our region and they recognized the importance of giving back,” said Olympic Hot Tub President Don Riling. “Hunger and homelessness often go hand-in-hand and go to the very core of our ability to have a foundation on which to build a happy, healthy existence.”

Olympic will donate a portion of each hot tub sale toward the Founder’s Event goal of $18,000 to benefit these food banks.

Olympic encourages community members to donate directly to their own local food bank or the three participating food banks. “Our company has always been focused on the health and wellness of our customers—one of the reasons we’ve adopted Better You…Better Life ™ as Olympic’s mantra. We think that everyone, regardless of their situation in life, deserves the most basic needs to survive. Hunger is a serious issue in Puget Sound, especially these days, and we hope to do our small part to help eradicate it. We’re hopeful our customers will agree and make our fourth Founder’s Event a significant contributor to these worthy food banks working to end hunger,” said Riling.

###

About Olympic Hot Tub:

http://www.olympichottub.com

Olympic Hot Tub has been in business 43-years and has six retail locations, Seattle, Everett, Issaquah, Auburn, Lacey, and Woodinville, as well as a service center in Auburn. The company is credited by The Seattle Times as introducing hot tubbing to the Pacific Northwest. Olympic Hot Tub has a focus on wellness and the health benefits of hot water.

ABOUT THE 3-LOCAL FOOD BANKS:

Rainier Valley Food Bank

http://www.rvfb.org/

Our mission is to nourish with good food, empower with knowledge, and serve with compassion. We offer assistance through the following programs:

1.    Home Delivery, during Covid 19 Restrictions- Food delivery is available to everyone within Seattle city limits, regardless of age, health, and income.

2.    To-Go Food Bag, for people without access to a kitchen and in need of pre-prepared foods.

3.    Backpack Program, for students and families experiencing food insecurity, attending South Seattle schools, in need of weekend groceries.

In 2018, Rainier Valley Food Bank provided groceries to 16,220 people 271,128 times through 78,628 food bank visits & deliveries. Our staff & volunteers delivered groceries 9,353 times to 246 homebound sick, elderly, & disabled people in South Seattle. From 2017 to 2018, the number of households we delivered to increase by nearly 30%. Our backpack program provided 5,712 backpacks of food to students at 7 schools. That’s a 215% growth from 2017 to 2018.From 2017 to 2018, the number of To-Go Bags requested by Seattle’s increasing homeless & transient populations nearly doubled.    

Marysville Community Food Bank

http://www.marysvillefoodbank.org/

Our mission is enhancing the lives of our neighbors by nourishing their bodies, hearts and souls to build a brighter future. We aid the community though these programs

1.    Drive through Food pick up – during Covid 19 Restrictions.

2.    Home Delivery- for persons who are physically disabled, with no alternatives for drive through pick up.

3.    Weekend food program

4.    Backpack program for students and families experiencing need.

The Marysville Community Food Bank receives over 80,000 pounds of usable product every month from individuals, food drives, and local grocery stores. This translates into $138,000 of value that we distribute to about 1,100 families each month. We receive additional monetary support from local churches, organizations, and individuals.

Less than 20% of our food comes directly from Northwest Harvest, Food Lifeline, and government food programs. Local support is crucial as we seek to help the hungry in our community.

Eloise’s Cooking Pot Food Bank

https://themadf.org/eloises-cooking-pot/


Eloise’s Cooking Pot Food Bank provides quality food to the communities of East and South Tacoma, Washington. Founder, Ahndrea Blue, was concerned about the children in these communities who were not eating on a regular basis due to their families experiencing economic hardship. Without government assistance, Ahndrea began delivering food to her tenants in this area. This is how the foundation for Eloise’s Cooking Pot Food Bank began. The food bank is named after Ahndrea’s grandmother Eloise. Eloise was a woman of humble means but would generously share whatever food she had by providing a hot meal to anyone who was in need.

In 2019, Eloise’s Cooking Pot,

  •     Served over 180,000 clients (more than 46,139 households)
  •     Distributed over 1.9 million pounds of food
  •     Served over 1.5 million meals

Eloise’s Cooking Pot is the largest independent food bank and the #1 food delivery service in Pierce County.

Eloise Cooking Pot Food Bank is a program under Making A Difference Foundation.

Share article on social media or email:

Webasto Introduces Lightweight, Compact HFT 300 and HFT 600 Air Cleaners With Medical-Grade HEPA-14 Filtration to Battle Airborne Pathogens in Vehicles


Webasto HFT 300 air cleaners, Webasto HFT 600 air cleaners, HEPA-14 air cleaners

The lightweight, compact, cylindrical units use medical-grade HEPA-14 filtration media and can be installed almost anywhere inside vehicles and in other confined spaces.

Webasto’s HFT 300 and HFT 600 high-efficiency air cleaners provide fleet operators with a practical, immediate and reliable solution for vehicles in service and on the road today. – Matt Wheeler

Webasto North America, a top-100 global tier-one automotive, commercial vehicle and aftermarket equipment manufacturer, announced the introduction of its HFT 300 and HFT 600 high-efficiency air cleaners. The lightweight, compact, cylindrical units use medical-grade HEPA-14 filtration media and can be installed almost anywhere inside vehicles and in other confined spaces where people may be sharing interior air.

The COVID-19 pandemic has brought with it an increased awareness of human respiration and its role in the transmission of disease. The enclosed environments of vehicles used to transport people now pose a health risk to operators and passengers alike. Emergency personnel in ambulances, commuters using public transportation, children riding on school buses, work crews in transit to jobsites, and their respective drivers all face an elevated risk of infection simply by breathing in close physical proximity to one another.

Emergency medical technicians (EMTs) face a far greater hazard due to their direct exposure to aerosolized viruses and bacteria emitted by patients during ambulance-based treatment. In fact, the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC) and the European Centre for Disease Prevention and Control (ECDC) all recommend HEPA-14 filtration and 60 air-changes-per-hour for infection control in ambulances.

Until now, HEPA-14 filtration systems have been large and unwieldy, and there were no retrofit units on the market that would universally fit existing ambulances, transit vehicles, school buses and crewed work trucks. With their high-velocity, twin-axial fan motors, Webasto’s new air cleaners have rapid air exchange rates that can meet or exceed WHO, CDC and ECDC guidelines for ambulances. The HFT 300 delivers up to 5 cubic meters of purified air per minute or 300 cubic meters per hour. The HFT 600 can process and clean up to 10 cubic meters of air per minute or 600 cubic meters per hour.

“Webasto’s HFT 300 and HFT 600 high-efficiency air cleaners provide fleet operators with a practical, immediate and reliable solution for vehicles in service and on the road today,” said Matt Wheeler, head of HVAC Light & Medium Duty for Webasto North America. “Our HFT units don’t impact a vehicle’s existing HVAC system and can complement other pathogen mitigation systems that come up short in meeting CDC, WHO and ECDC air-change recommendations. Their compact size, quiet operation, robust design and ease of installation enables them to be rapidly deployed, providing prophylactic air purification protection for large populations of vehicles – today.”

With their high-efficiency HEPA-14 filters, the HFT 300 and HFT 600 remove 99.995% of airborne particles equal to or greater than 0.3 microns. A single intake port is located on one end of the unit and decontaminated air is released in all directions, around its circumference. Each unit’s filter monitoring feature senses when its filter needs to be changed and an LED light alerts users when it’s time for maintenance. Most filters should be expected to last between 6 to 12 months.

Filter changes are fast, simple and safe; and a filter-handling tool provided with each replacement filter helps isolate and contain contaminants during filter replacement and disposal. Both HFT 300 and HFT 600 systems use commercially available, cylindrical H14 filters. Their rugged design, leak-free operation and two-part seal make the HFT 300 and HFT 600 suitable for a wide variety of applications.

The lightweight HFT 300 and HFT 600 high-efficiency air cleaners have integrated mounting brackets and were designed for ease of retrofitting. Both models are compatible with 12- and 24-volt electrical systems and optional wire harness kits, including mating connectors, fuse, fuse holder and ring terminals, are also available.

“Our HEPA-14 air cleaners provide the medical-grade atmospheric filtration that is universally accepted as a key to eliminating pathogens from interior environments,” Wheeler said. “And although they can’t replace appropriate personal protective equipment (PPE) and social distancing in the fight against the coronavirus and other infectious agents, they can provide a vital means of risk reduction in the battle.”

To access images of Webasto’s new HFT 300 and HFT 600 high-efficiency air cleaners, please visit: visit: http://www.webastohepafilter.com

***

About Webasto:

The Webasto Group is a global innovative systems partner to almost all automobile manufacturers and among the top 100 suppliers in this industry sector. The company’s product portfolio comprises a broad range of roof and heating systems for every type of vehicle and all drive types as well as battery systems and charging solutions. Moreover, Webasto has a strong position in the aftermarket providing dealers and end customers with customized solutions and services relating to thermo management and electromobility. In 2019 the company generated sales of around 3.7 billion euros and had almost 14,000 employees at more than 50 locations (with over 30 of these being manufacturing plants). The headquarters of the company, founded in 1901, is located in Stockdorf near Munich (Germany). For more information please visit http://www.webasto-group.com / http://www.twitter.com/WebastoGroup

Corporate Contact:                    

Aubrey Stewart

Marketing Communications Specialist            

Phone: 810-593-6062

E-Mail: Aubrey.Stewart@webasto.com

Share article on social media or email:



The Termeer Foundation Awards Henri Termeer Fellowships for 2020 and Opens 2021 Application Process


The Termeer Foundation believes many healthcare challenges can be solved through the mentoring, support, communication and shared experience provided through our network.

The Termeer Foundation, a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines, today announced the recipients of the Henri Termeer Fellowship for 2020 and opened its application process for 2021.

The Henri Termeer Fellowship is awarded each year to up-and-coming company founders, CEOs or heads of life science organizations who are working to bring life-changing treatments to patients. Recipients are often early in their leadership career trajectory, such as first-time CEOs, and place a high priority on connectivity, community, mentoring, and seeing the value in other people from all walks of life. Fellows receive membership in The Henri Termeer Network, an ever-expanding group of emerging and established healthcare leaders who pool their collective experience to advance cures. Additional Fellowship benefits include quarterly mentor presentations, monthly peer-to-peer learning presentations, individual 1:1 mentoring, and access to other events and initiatives sponsored by The Termeer Foundation.

“The Henri Termeer Fellowship Program is inspired by Henri, who was deeply committed to supporting and mentoring life science professionals. Henri was actively mentoring nearly 50 CEOs at the time of his passing and coached hundreds more throughout the course of his career,” said Belinda Termeer, President of The Termeer Foundation. “The Termeer Foundation believes many healthcare challenges can be solved through the mentoring, support, communication and shared experience provided through our network.”

The 2020 Henri Termeer Fellows

Hasan Celiker, Xeno Biosciences

Hasan is the founder and CEO of Xeno Biosciences, a biopharmaceutical company developing novel therapeutics for obesity and related metabolic diseases. He previously worked as a consultant at start-up companies in diverse technology areas such as synthetic biology, nanotechnology to agriculture. He earned his Ph.D. at MIT in Electrical Engineering & Computer Science and completed doctorate work on the evolution of cooperation and interspecies interactions in microbial ecosystems.

Tim Knotnerus, AgomAb Therapeutics

Tim is CEO of AgomAb Therapeutics, a privately held Belgian based biotech company developing hepatocyte growth factor (HGF) mimetic antibodies. While the company’s antibodies maintain the full therapeutic potential of HGF, they display the excellent drug-like properties of antibodies, holding the promise for regeneration of tissues in a variety of clinical indications. In March 2019, the team closed a $23 million series A financing round from a syndicate of venture capital and strategic investors to fund the non-clinical development of the lead compound. Prior to AgomAb, Tim was VP Corporate Development at AM-Pharma where he and the team conducted a phase IIb trial in patients with sepsis-associated acute kidney injury, signed a $600M option-to-acquisition deal with Pfizer and raised a $133M private financing round. Prior to that, Tim was a senior associate at Aescap Venture, a venture capital fund investing in European medical companies. Tim holds an executive MBA from IMD (Switzerland), where he was named Valedictorian, and gained a Science and Innovation Masters and a Drug Innovation Masters, both with honors from Utrecht University (NL).

Natalie Yivgi Ohana, Minovia Therapeutics

Natalie the scientific founder and CEO of Minovia Therapeutics, a clinical-stage biotechnology company focused on developing innovative cell therapies for mitochondrial diseases. She received her Ph.D. in Biochemistry from The Hebrew University and performed her postdoctoral fellowship at the Weizmann Institute of Science. She has over twenty years’ experience in mitochondrial research and currently leads the global organization in Israel, the U.S. and Switzerland.

Stan Wang M.D., Ph.D., Thymmune Therapeutics

Stan is founder and CEO of Thymmune Therapeutics, an innovative cell therapy company working to address high unmet needs across immunology. Previously, Stan was Founding Chief Scientific Officer at Cellino Biotech, where he led R&D and application of its technology to rapidly engineer cells. Stan received his Ph.D. from the University of Cambridge and his M.D. from Columbia University. He was a postdoctoral fellow in cell and gene therapy with George Church at Harvard Medical School.

Minmin (Mimi) Yen, PhagePro

Mimi is CEO and Co-Founder of PhagePro, an early-stage biotechnology therapeutics company that develops bacteriophage-based products to help the world’s most vulnerable communities. Previously Mimi earned her Ph.D. in microbiology at Tufts University and completed research on cholera in the Camilli Lab. She also pursued a Master’s in Public Health at Boston University, specializing in Program Management and Global Health.

Applications are now open for the Henri Termeer Fellows class of 2021 and will be accepted through December 31, 2020. Apply online at http://www.termeerfoundation.org. Applications are reviewed by The Termeer Foundation Board of Directors and a rotating group of Mentor volunteers. Notifications will be sent out in the first quarter of 2021. The Termeer Foundation is committed to ensuring the inclusiveness of its Fellowship program, particularly in recognition of the underrepresentation of women and Black, Brown and Indigenous People of Color at the CEO level within the biopharmaceutical industry.

About The Termeer Foundation

Building on the bold legacy of Henri Termeer, who pioneered groundbreaking treatments for rare diseases, The Termeer Foundation connects life science innovators and catalyzes the creation of new medicines. The Foundation’s network of emerging and established healthcare innovators cultivates tomorrow’s leaders and leverages their collective expertise to solve complex problems in drug development and accessibility. The Foundation also integrates its network with academic institutions, nonprofits, regulatory agencies and other organizations across the global healthcare ecosystem to provide expert counsel, stimulate innovation, eliminate barriers to progress, and ultimately connect the world of healthcare until every patient has a cure. Visit us at http://www.termeerfoundation.org or on LinkedIn @TermeerFoundation.

Share article on social media or email:

Introducing: The Unforgotten Families


The Unforgotten Families (TUF), a resource of support to the community of families faced with the challenges of caring for a medically fragile child, is celebrating the launch of their website and social media platforms.

The new site will be home to the real “Unforgotten Families” and provides a central, focused and virtual location for educating families on the solution and impact to the community that can be provided through the Family CNA Program.

The Family CNA Program is revolutionizing home healthcare by providing medically fragile children with the care they deserve through allowing family members to become trained and certified to care for their loved ones. The Family CNA Program ushers in a new era of home care innovation by offering comprehensive training and support for this medically fragile population.

“Our Family CNA Program allows family members to be trained, certified caregivers for their loved ones at no cost to the state or family members,” states Fred Johnson, President, and CFO of Team Select Home Care, the training company behind The Unforgotten Families. “This in turn solves the staffing crisis that often has families receiving partial care or experiencing extended facility/NICU stays pending arrangement of home nursing.”

The launch of http://www.theunforgottenfamilies.com is vital in linking families to life-saving, life-affirming resources, especially in the time of COVID-19 where the importance of federally qualified healthcare workers is taking center stage.

“No one can bring the same level of passion and attention to caregiving as a parent can for their own child,” stated Johnson. “Parents not only provide the highest quality of support but also ensure an on-going continuity of care.”

For Team Select Home Care, this means humanizing the struggles that families of medically fragile children go through. The average American family spends $284,570 in basic care for a child, but for a family with a medically fragile child that number can almost triple. Common struggles experienced by families with medically fragile children can include financial instability from frequent hospital visits and medical bills, career instability due to parents needing to be “on call” for children in case their caregiver is unable to visit the home, and relationship strain due to the financial and emotional stress. The family profiles and communal rethinking that will come from the launch of the TUF website will frame, engage, and impact the state-by-state legislation to urgently adopt the program. Currently, the Family CNA program has only been implemented in Colorado where medically fragile children and their families have been participating for over 20 years.

To learn more, visit http://www.theunforgottenfamilies.com

About The Unforgotten Families (TUF)

The Unforgotten Families (TUF) is an awareness campaign created to highlight the many challenges faced by medically fragile children and their families. The TUF campaign is powered by Team Select Home Care and their Family CNA Program which provides improved access to care, increased quality of care, and job creation through allowing family members to be trained, certified caregivers for their loved ones at no cost to the state or family members. No one can bring the same level of passion and attention to caregiving as a parent can for their own child. Parents not only provide the highest quality of support, but also ensure an on-going continuity of care. This solves the nurse staffing crisis, resulting in increased capacity to care for a larger number of medically fragile children. Please visit http://www.theunforgottenfamilies.com for more information.

About Team Select Home Care

Dedicated to improving the lives of patients through increased health and mobility, Team Select Home Care maintains offices in Arizona, Colorado, Missouri, California, Texas, Illinois, Indiana and New Jersey that provides home health care and other services to their local communities. The company was established in 2008 with the goal of bringing together the most experienced and ethical home health professionals in the industry. For additional information, please visit https://teamselecthh.com.

Share article on social media or email:

Bamboo Toothbrushes “Destined to Die” Ponder Their Short Existence in Campaign From Goodwell Co. and Undnyable


Goodwell.co’s First Branding Work from Undnyable

“Goodwell Co.’s bamboo toothbrushes are literally born to die,” said Founder and Chief Creative Officer of Undnyable Justin Hooper. “We wanted to show that in the most fun and irreverent way possible, while still driving home the environmental benefits.”

Sustainable oral care startup Goodwell Co. recently partnered with Portland based agency Undnyable to concept and produce their first brand work for their bamboo toothbrushes through a series of TV, digital films and social posts.

“With over 850 million plastic toothbrushes ending up in landfills every year, pretty much every single plastic toothbrush ever made is still sitting around someplace, waiting a century to decompose,” said Patrick Triato, Founder and CEO of Goodwell Co. “We needed a campaign to show that, in comparison to plastic toothbrushes, Goodwell Co. bamboo toothbrushes are made from and give back to the earth, rather than continue to pollute it.”

The Undnyable team created a series of three spots, each profiling a Goodwell Co. bamboo toothbrush going about their day, destined to come to an end for the greater good of the planet.

“Goodwell Co.’s bamboo toothbrushes are literally born to die,” said Founder and Chief Creative Officer of Undnyable Justin Hooper. “We wanted to show that in the most fun and irreverent way possible, while still driving home the environmental benefits.”

The campaign, shot in three locations during COVID and finished with the help of a team spread across three states, will air in broadcast and digital as three :30 TV spots and a series of social posts. In the TV spots, Goodwell Co. bamboo toothbrushes wax poetically about their daily life and their very timely, inevitable demise.

The campaign, available here, was conceived by Undnyable, directed by Justin Hooper and launches on October 1, 2020.

ABOUT UNDNYABLE

Founded by long time agency veteran Justin Hooper, Undnyable is the cure for the common creative agency. Our success model is efficiency and effectiveness through high-impact creativity, shedding the costs and layers of more traditional agencies. We’ve worked inside brands, inside agencies and production companies and across all creative and production roles. Our capabilities include navigating relationships with AOR and brand partners, bolstering and training currently existing creative and marketing teams as well as creating and producing fully integrated campaigns from start to finish. For more information visit: http://www.undnyable.com.

ABOUT GOODWELL CO.

Goodwell Co. is on a bold mission to pioneer more sustainable and well-designed oral care in a staid billion dollar industry. We are dedicated to carbon neutral processes and practices that help enhance and empower the human ritual of personal care, through innovation, technology and design. By utilizing the latest in recyclable and compostable materials, the user receives oral care essentials that look great, work well, and do good for the planet at the same time. For more information and to purchase Goodwell Co. products, please see http://www.Goodwell.co.

CAMPAIGN CREDITS

Campaign Title: Toothbrushes that don’t last

Spot Titles: “Pandas”, “Reincarnated” & “The Nomadic Life”

Client: Goodwell Co.

Founder & Chief Executive Officer: Patrick Triato

Director of Design & Development: Charlie McArthur

Director of Operations & Partnerships: Julie Byun-Reinhardt

Agency: Undnyable

Chief Creative Officer/Founder: Justin Hooper

Creative Director: Phil Glist

Executive Producer: Melissa Hooper

Director of Media: Michelle Murphy

Contributor: Dino Spadavecchia

Production Company: Undnyable

Director: Justin Hooper

Audio Post: Lucky Day, Portland

Executive Producers: Chris Vanderloo, Edward Gouttierre

Voice Over Casting: In Both Ears

Seattle Audio Mix & Sound Design: Pure Audio

Los Angeles Audio Mix & Sound Design: Laszlophonics

Los Angeles Mixer/Sound Design: Christian Laszlo

Share article on social media or email: